HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.

Abstract
Presently, commercially available cell culture rabies vaccines for humans and animals consist of the five inactivated rabies virus proteins. The vaccines elicit a CD4+ helper T-cell response and a humoral B-cell response against the viral glycoprotein (G) resulting in the production of virus neutralizing antibody. Antibody against the viral nucleoprotein (N) is also present, but the mechanism(s) of its protection is unclear. HIV-infected individuals with low CD4+ T-lymphocyte counts and individuals undergoing treatment with immunosuppressive drugs have an impaired neutralizing antibody response after pre- and post-exposure immunization with rabies cell culture vaccines. Here we show the efficacy of live vaccinia-rabies virus recombinants, but not a cell culture vaccine consisting of inactivated rabies virus, to elicit elevated levels of neutralizing antibody in B-lymphocyte deficient A/WySnJ mice. The cell culture vaccine also failed to protect the mice, whereas a single immunization of a vaccinia recombinant expressing the rabies virus G or co-expressing G and N equally protected the mice up to 18 months after vaccination. The data suggest that recombinant poxviruses expressing the rabies virus G, in particular replication defective poxviruses such as canarypox or MVA vaccinia virus that undergo abortive replication in non-avian cells, or the attenuated vaccinia virus NYVAC, should be evaluated as rabies vaccines in immunocompromised individuals.
AuthorsDonald L Lodmell, Joseph J Esposito, Larry C Ewalt
JournalVaccine (Vaccine) Vol. 22 Issue 25-26 Pg. 3329-33 (Sep 3 2004) ISSN: 0264-410X [Print] Netherlands
PMID15308356 (Publication Type: Journal Article)
Chemical References
  • Rabies Vaccines
  • Vaccines, Attenuated
  • Vaccines, Synthetic
Topics
  • Animals
  • Antibody Formation (genetics)
  • B-Lymphocytes (physiology)
  • Cells, Cultured
  • Female
  • Immunocompromised Host (genetics, immunology)
  • Mice
  • Mice, Inbred Strains
  • Mutation (genetics, physiology)
  • Neutralization Tests
  • Rabies (prevention & control)
  • Rabies Vaccines (immunology)
  • Rabies virus (immunology)
  • Vaccines, Attenuated (immunology)
  • Vaccines, Synthetic (immunology)
  • Vaccinia virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: